Annual Shareholders Equity
$465.09 M
-$334.44 M-41.83%
December 31, 2024
Summary
- As of March 10, 2025, SAGE annual stockholders equity is $465.09 million, with the most recent change of -$334.44 million (-41.83%) on December 31, 2024.
- During the last 3 years, SAGE annual shareholders equity has fallen by -$1.26 billion (-73.10%).
- SAGE annual shareholders equity is now -77.56% below its all-time high of $2.07 billion, reached on December 31, 2020.
Performance
SAGE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$465.09 M
-$86.75 M-15.72%
December 31, 2024
Summary
- As of March 10, 2025, SAGE quarterly stockholders equity is $465.09 million, with the most recent change of -$86.75 million (-15.72%) on December 31, 2024.
- Over the past year, SAGE quarterly shareholders equity has dropped by -$162.97 million (-25.95%).
- SAGE quarterly shareholders equity is now -77.56% below its all-time high of $2.07 billion, reached on December 31, 2020.
Performance
SAGE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
SAGE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.8% | -25.9% |
| 3 y3 years | -73.1% | -73.1% |
| 5 y5 years | -50.8% | -50.8% |
SAGE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.1% | at low | -73.1% | at low |
| 5 y | 5-year | -77.6% | at low | -77.6% | at low |
| alltime | all time | -77.6% | +1574.8% | -77.6% | +1138.3% |
Sage Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $465.09 M(-41.8%) | $465.09 M(-15.7%) |
| Sep 2024 | - | $551.84 M(-12.1%) |
| Jun 2024 | - | $628.06 M(-11.0%) |
| Mar 2024 | - | $705.80 M(-11.7%) |
| Dec 2023 | $799.53 M(-36.2%) | $799.53 M(-2.1%) |
| Sep 2023 | - | $816.66 M(-17.0%) |
| Jun 2023 | - | $984.38 M(-13.1%) |
| Mar 2023 | - | $1.13 B(-9.5%) |
| Dec 2022 | $1.25 B(-27.6%) | $1.25 B(-9.2%) |
| Sep 2022 | - | $1.38 B(-8.3%) |
| Jun 2022 | - | $1.50 B(-7.1%) |
| Mar 2022 | - | $1.62 B(-6.4%) |
| Dec 2021 | $1.73 B(-16.6%) | $1.73 B(-5.8%) |
| Sep 2021 | - | $1.84 B(-4.9%) |
| Jun 2021 | - | $1.93 B(-3.7%) |
| Mar 2021 | - | $2.00 B(-3.3%) |
| Dec 2020 | $2.07 B(+119.4%) | $2.07 B(+215.1%) |
| Sep 2020 | - | $657.58 M(-11.1%) |
| Jun 2020 | - | $739.91 M(-12.9%) |
| Mar 2020 | - | $849.21 M(-10.1%) |
| Dec 2019 | $944.65 M | $944.65 M(-12.6%) |
| Sep 2019 | - | $1.08 B(-10.1%) |
| Jun 2019 | - | $1.20 B(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $1.32 B(+52.9%) |
| Dec 2018 | $862.97 M(+81.5%) | $862.97 M(-12.7%) |
| Sep 2018 | - | $988.50 M(-8.3%) |
| Jun 2018 | - | $1.08 B(+1.7%) |
| Mar 2018 | - | $1.06 B(+122.8%) |
| Dec 2017 | $475.48 M(+29.0%) | $475.48 M(+137.7%) |
| Sep 2017 | - | $200.05 M(-23.1%) |
| Jun 2017 | - | $260.30 M(-18.3%) |
| Mar 2017 | - | $318.45 M(-13.6%) |
| Dec 2016 | $368.52 M(+112.2%) | $368.52 M(-10.9%) |
| Sep 2016 | - | $413.74 M(+60.9%) |
| Jun 2016 | - | $257.21 M(-10.5%) |
| Mar 2016 | - | $287.50 M(+65.5%) |
| Dec 2015 | $173.69 M(+42.5%) | $173.69 M(-12.3%) |
| Sep 2015 | - | $198.10 M(-8.9%) |
| Jun 2015 | - | $217.45 M(+104.2%) |
| Mar 2015 | - | $106.51 M(-12.6%) |
| Dec 2014 | $121.89 M(-486.5%) | $121.89 M(-8.3%) |
| Sep 2014 | - | $132.92 M(-396.7%) |
| Jun 2014 | - | -$44.79 M(-183.5%) |
| Mar 2014 | - | $53.65 M(-270.1%) |
| Dec 2013 | -$31.54 M(+135.4%) | -$31.54 M |
| Dec 2012 | -$13.39 M | - |
FAQ
- What is Sage Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Sage Therapeutics?
- What is Sage Therapeutics annual shareholders equity year-on-year change?
- What is Sage Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Sage Therapeutics?
- What is Sage Therapeutics quarterly shareholders equity year-on-year change?
What is Sage Therapeutics annual stockholders equity?
The current annual shareholders equity of SAGE is $465.09 M
What is the all time high annual shareholders equity for Sage Therapeutics?
Sage Therapeutics all-time high annual stockholders equity is $2.07 B
What is Sage Therapeutics annual shareholders equity year-on-year change?
Over the past year, SAGE annual stockholders equity has changed by -$334.44 M (-41.83%)
What is Sage Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of SAGE is $465.09 M
What is the all time high quarterly shareholders equity for Sage Therapeutics?
Sage Therapeutics all-time high quarterly stockholders equity is $2.07 B
What is Sage Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, SAGE quarterly stockholders equity has changed by -$162.97 M (-25.95%)